Biotech companies can quickly analyze data from current trials and revisit data from previous trials.
Biotech companies can quickly analyze data from current trials and revisit data from previous trials. This analysis and ability to combine vast datasets offers the insight needed to provide a more accurate diagnosis, and ultimately, devise enhanced medicines and treatment paths for patients.